LifeStance Health Group, a leading U.S. outpatient mental health provider, saw its stock drop 3.23% recently but still gained about 2% over the past month. The company offers therapy and psychiatry services both virtually and in person, serving a growing market for accessible mental healthcare. With a strong growth potential of 11.40% and a target price of $12.17, the stock may appeal to investors looking for future gains. Additionally, LifeStance's solid financial health is reflected in a high Piotroski Score of 8, indicating strong fundamentals.
Following strong Q1 2026 earnings, Jefferies analyst Linda Tsai raised the price target for American Homes 4 Rent from around $35.70 to $43.00. This significant increase reflects improved confidence in the company's performance and outlook as a leadi...
Pearson announced the winners of the 2026 Adobe Certified Professional World Championship, a global contest for students aged 13 to 22 who earned Adobe certifications in Photoshop, Illustrator, or InDesign. The event, held in Anaheim, CA, featured 56...
Morgan Fong, Chief Legal Officer at Maplebear, sold 18,390 shares of the company, generating $815,400 in proceeds. This insider sale could indicate personal financial planning or a shift in confidence, which investors often watch closely. The impact ...
Bloom Energy reported a 165.5% revenue increase to $1.07 billion and a 680% jump in operating earnings per share for Q2 2026, driven by rising demand from AI data centers. Despite this strong financial performance, Jefferies lowered its price target ...
Humana's stock was upgraded to Outperform by Evercore ISI following strong Q2 2026 results. The company reported adjusted earnings of $7.61 per share and revenues of $40.9 billion, both exceeding analyst expectations, driven by a 20.7% growth in medi...
